Here is the price of the promising drug in the fight against coronavirus

The drug, manufactured by the pharmaceutical company Gilead, is currently the only one approved for use against coronavirus in the United States by the FDA (Food and Drug Administration). Remdesivir treatment against COVID-19 will cost an average of $ 3,120 for patients with voluntary insurance in the US. The drug has so far been distributed free of charge, but starting on July 1, it will cost more than $ 3,000. On June 26, Remdesivir became the first COVID-19 drug. The European Medicines Agency (EMA) has approved it for the treatment of patients affected by coronavirus infection, children over 12 years of age and adults who show symptoms of respiratory distress and need respirators. Meanwhile, more than 30 drugs and vaccines are being tested worldwide against Covid-19. In May, the US authorized the use of this antiviral, created until yesterday to fight Ebola.